g): Phase 3 VALIANT Trial

Overview of attention for article published in Journal of the American Society of Nephrology, October 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 2 news outlets

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Article details
Title	Pegcetacoplan for 52 Weeks Results in Sustained Proteinuria Reduction to Remission (≤0.5 g/g) and Normalization (≤0.2 g/g): Phase 3 VALIANT Trial
Published in	Journal of the American Society of Nephrology, October 2025
DOI	10.1681/asn.2025da4gcc32
Authors	Carla M. Nester, Fadi Fakhouri, Daniel P. Gale, Andrew S. Bomback, Christoph Licht, Giuseppe Remuzzi, Nicole Van De Kar, Katie Gordon, Anwesha Mukherjee, Johan Szamosi, Lucia Quintana, Matthew C. Pickering

View on publisher site Alert me about new mentions

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2025.

All research outputs

#2,721,176

of 29,682,718 outputs

Outputs from Journal of the American Society of Nephrology

#1,481

of 6,567 outputs

Outputs of similar age

#23,553

of 326,081 outputs

Outputs of similar age from Journal of the American Society of Nephrology

#11

of 71 outputs

Altmetric has tracked 29,682,718 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 6,567 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.0. This one has done well, scoring higher than 76% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,081 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.

We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.